Log in

Relevant bibliographies by topics / Cancer ratio

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Cancer ratio'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cancer ratio.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cancer ratio"

1

Atchyuta, M., I. V. Renuka, P. Premalatha, PAV Krishnamacharyulu, Chitturi Ramya, and U. Pravallika. "Lymphnodal Ratio in Prognostication of Stage III Colon Cancer." Indian Journal of Pathology: Research and Practice 8, no. 2 (2019): 153–58. http://dx.doi.org/10.21088/ijprp.2278.148x.8219.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Verma, Akash, Rucha S. Dagaonkar, Dominic Marshall, John Abisheganaden, and R. W. Light. "Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)." Canadian Respiratory Journal 2016 (2016): 1–6. http://dx.doi.org/10.1155/2016/7348239.

Full text

Abstract:

Background. We performed prospective validation of the cancer ratio (serum LDH : pleural ADA ratio), previously reported as predictive of malignant effusion retrospectively, and assessed the effect of combining it with “pleural lymphocyte count” in diagnosing malignant pleural effusion (MPE).Methods. Prospective cohort study of patients hospitalized with lymphocyte predominant exudative pleural effusion in 2015.Results. 118 patients, 84 (71.2%) having MPE and 34 (28.8%) having tuberculous pleural effusion (TPE), were analysed. In multivariate logistic regression analysis, cancer ratio, serum L

APA, Harvard, Vancouver, ISO, and other styles

3

Eruku, Dr Baburao. "Differentiating malignant effusions from other exudative effusions by cancer ratio and cancer ratio plus." International Journal of Advanced Research in Medicine 3, no. 2 (2021): 525–29. http://dx.doi.org/10.22271/27069567.2021.v3.i2h.453.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ellis, Libby, Aurélien Belot, Bernard Rachet, and Michel P. Coleman. "The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival." Journal of Global Oncology, no. 5 (December 2019): 1–9. http://dx.doi.org/10.1200/jgo.19.00038.

Full text

Abstract:

PURPOSE The ratio of cancer mortality and cancer incidence rates in a population has conventionally been used as an indicator of the completeness of cancer registration. More recently, the complement of the mortality-to-incidence ratio (1-M/I) has increasingly been presented as a surrogate for cancer survival. We discuss why this is mistaken in principle and misleading in practice. METHODS We provide an empirical assessment of the extent to which trends in the 1-M/I ratio reflect trends in cancer survival. We used national cancer incidence, mortality and survival data in England to compare tre

APA, Harvard, Vancouver, ISO, and other styles

5

Abhinav, Manish, Garg Nita, and Sharma Narotam. "Serum CA125, CEA, CA125/CEA ratio and LDH levels in Ovarian Cancer." Indian Journal of Genetics and Molecular Research 7, no. 1 (2018): 17–20. http://dx.doi.org/10.21088/ijgmr.2319.4782.7118.3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Fujisawa, Daisuke, Shino Umezawa, Maiko Fujimori, and Mitsunori Miyashita. "Prevalence and associated factors of perceived cancer-related stigma in Japanese cancer survivors." Japanese Journal of Clinical Oncology 50, no. 11 (2020): 1325–29. http://dx.doi.org/10.1093/jjco/hyaa135.

Full text

Abstract:

Abstract This study aimed to examine the prevalence and associated factors of perceived cancer-related stigma among Japanese cancer survivors. In this web-based survey involving 628 Japanese cancer survivors, perceived cancer-related stigma, quality of life (Quality of Life-Cancer Survivors Instrument), psychological distress (K6) and perceived social support (multidimensional scale of perceived social support) were evaluated. Perceived cancer-related stigma was endorsed by 61.2% of the participants. Perceived cancer-related stigma was significantly associated with quality of life (R = 0.35–0.

APA, Harvard, Vancouver, ISO, and other styles

7

P. G., Naveen, and K. Veena L. Karanth. "Derived neutrophil by lymphocytes ratio is a misnomer, implication of derived leucocytes ratio in diagnosing gastric cancers." International Surgery Journal 6, no. 1 (2018): 82. http://dx.doi.org/10.18203/2349-2902.isj20185187.

Full text

Abstract:

Background: Gastric malignant neoplasms are well-known common malignant disease seen in routine clinical practice. In India incidence are comparatively low but accounts for significant mortality and morbidity. Gastric malignancy incidence adds significant numbers every year to cancer related deaths worldwide. And prognosis is not satisfactory in spite of medical innovations and technological advancements. Early diagnosis helps for successful surgical removal of gastric cancer and to achieve a curative resections. Present study objectives are to solve the paradox of misnomer derived neutrophil

APA, Harvard, Vancouver, ISO, and other styles

8

Kim, Sunsuk, Moon Kyung Joo, Jong-Jae Park, et al. "Neutrophil-to-lymphocyte ratio to predict metachronous cancer after curative resection of early gastric cancer." Journal of Clinical Oncology 42, no. 3_suppl (2024): 313. http://dx.doi.org/10.1200/jco.2024.42.3_suppl.313.

Full text

Abstract:

313 Background: We investigate the predictive value of inflammatory markers for occurrence of metachronous cancers among patients who underwent endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) and are judged as curative resection (CR). Methods: We enrolled patients who were diagnosed as EGC and underwent ESD during 2006 and 2020. We retrospective collected data of inflammatory indexes such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and erythrocyte sediment ratio (ESR). Results: A total of 1,011 patients underwent ESD for EGC, achieved CR an

APA, Harvard, Vancouver, ISO, and other styles

9

Gawiński, Cieszymierz, Andrzej Mróz, Katarzyna Roszkowska-Purska, et al. "A Prospective Study on the Roles of the Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Locally Advanced Rectal Cancer." Biomedicines 11, no. 11 (2023): 3048. http://dx.doi.org/10.3390/biomedicines11113048.

Full text

Abstract:

Rectal cancer constitutes over one-third of all colorectal cancers (CRCs) and is one of the leading causes of cancer-related deaths in developed countries. In order to identify high-risk patients and better adjust therapies, new markers are needed. Systemic inflammatory response (SIR) markers such as LMR, NLR, and PLR have proven to be highly prognostic in many malignancies, including CRC; however, their roles in locally advanced rectal cancer (LARC) are conflicting and lack proper validation. Sixty well-selected patients with LARC treated at the Maria Sklodowska-Curie National Research Instit

APA, Harvard, Vancouver, ISO, and other styles

10

Yasuda, Koji. "The correlation of neutrophil/lymphocyte ratio and tumor reduction ratio in preoperative chermoradiotherapy for advanced rectal cancer." Journal of Clinical Oncology 32, no. 3_suppl (2014): 633. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.633.

Full text

Abstract:

633 Background: Preoperative chemoradiotherapy (CRT) is widely used for the treatment of advanced lower rectal cancer and is considered to reduce the local recurrence rate and improve the anus preservation rate. However, the tumor reduction effect varies among patients, and thus far, no factor has yet been found to be effective in the prediction of therapeutic efficacy. Recent studies have shown tumor immunity in the tumor microenvironment to be involved in the anti-tumor effect of radiation and anti-cancer drugs. Among these studies, some show that the neutrophil/lymphocyte (NL) ratio in bloo

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Cancer ratio"

1

Lee, Karin L. "High Aspect Ratio Viral Nanoparticles for Cancer Therapy." Case Western Reserve University School of Graduate Studies / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=case1467714833.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Stenning, Persivale Karoline Andrea, Franco Maria Jose Savitzky, Alejandra Cordero-Morales, et al. "The mortality-incidence ratio as an indicator of five-year cancer survival in metropolitan Lima." Cancer Intelligence, 2018. http://hdl.handle.net/10757/622636.

Full text

Abstract:

Introduction: The Mortality–Incidence Ratio complement [1 – MIR] is an indicator validated in various populations to estimate five-year cancer survival, but its validity remains unreported in Peru. This study aims to determine if the MIR correlates directly with five-year survival in patients diagnosed with the ten most common types of cancer in metropolitan Lima. Materials and methods: The Metropolitan Lima Cancer Registry (RCLM in Spanish) for 2004–2005 was used to determine the number of new cases and the number of deaths of the following cancers: breast, stomach, prostate, thyroid, lung, c

APA, Harvard, Vancouver, ISO, and other styles

3

Gunnarsson, Niklas. "Chronic myeloid leukemia and cancer." Doctoral thesis, Umeå universitet, Medicin, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-141144.

Full text

Abstract:

Background Chronic myeloid leukemia (CML) is a relatively rare hematological malignancy with a constant incidence of approximately 90 new cases each year in Sweden (0.9 cases/100 000 inhabitants). The etiology is largely unknown but high doses of ionizing radiation are a known but rare risk factor. The treatment options were for a long time limited to chemotherapies i.e. hydroxyurea and busulfan, interferon’s and allogeneic hematopoietic stem cell transplantation and the median survival were only about four years. Since the beginning of the 21st century a new way of treating CML has been intr

APA, Harvard, Vancouver, ISO, and other styles

4

Cameron, David. "Alterations in the apoptotic-mitotic ratio : an early indicator of breast cancer sensitivity to tamoxifen." Thesis, University of Edinburgh, 1997. http://hdl.handle.net/1842/21677.

Full text

Abstract:

The use of the Gompertz function, an accurate model of xenograft growth, could be used to predict subsequent tumour behaviour and thus identify responsive disease. The aim of this study was therefore to determine the relationship between tumour response to tamoxifen and changes in apoptosis and mitosis, to confirm their chronology and specificity in a model system, and to assess the possibility of identifying these changes in fine needle aspirates (FNAs) rather than biopsy material. In a cohort of 50 post-menopausal women with ER positive breast cancer treated with tamoxifen, the level of expr

APA, Harvard, Vancouver, ISO, and other styles

5

Foroughi, pour Ali. "Linear Approximations for Second Order High Dimensional Model Representation of the Log Likelihood Ratio." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1555419601408423.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

KIKOSADA, Yasutomi, Hisatoshi MAEDA, Manabu ANDOH та ін. "異数倍数体を示す上咽頭腫瘍におけるmagnetization transfer ratio". 日本磁気共鳴医学会, 1996. http://hdl.handle.net/2237/19431.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Boudria, Asma. "Les variants d'épissage du VEGF-A : leur rôle dans la progression et la réponse aux thérapies anti-angiogéniques des carcinomes pulmonaires." Thesis, Grenoble, 2014. http://www.theses.fr/2014GRENV010/document.

Full text

Abstract:

Le VEGF-A est l'un des facteurs de croissance les plus importants au cours de la néo-angiogénèse tumorale. Ce rôle en a fait une cible de choix pour le développement de thérapies. Ainsi, différents médicaments le ciblant (Bevacizumab, AvastinR) ou ciblant ses voies de signalisation (inhibiteurs des récepteurs VEGFR) sont actuellement utilisés en clinique, notamment dans les adénocarcinomes pulmonaires. Cependant, malgré des résultats initiaux prometteurs, un grand nombre de patients apparaissent d'emblée résistants ou échappent à ces thérapies, voir même développent des tumeurs plus agressives

APA, Harvard, Vancouver, ISO, and other styles

8

Kardeby, Caroline. "The Concordance between Immunohistochemical Staining and Silver In Situ Hybridization for HER2 Status in Breast Cancer Tissue Samples." Thesis, Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-154951.

Full text

Abstract:

The human epidermal growth factor receptor-2 (HER2) protein has been associated with breast cancer progression and the HER2 status can be used to determine the type of treatment for each breast cancer patient. The purpose of this study was to examine the HER2 protein and gene statuses in breast cancer tissue samples using two methods and analyze the concordance between them. Ten paraffin-embedded, formaldehyde-fixed breast cancer tissue samples from the Biobank at the Department of Pathology and Cytology at Sundsvall Hospital were analyzed in this study. All samples were from women born betwee

APA, Harvard, Vancouver, ISO, and other styles

9

Souza, Lima Nathalia Caroline de 1989. "Relation between digit ratio (2D:4D) and malignant and benign breast lesions = Relação entre proporção digital (2D:4D) e lesões malignas e benignas de mama." [s.n.], 2014. http://repositorio.unicamp.br/jspui/handle/REPOSIP/289238.

Full text

Abstract:

Orientador: Jacks Jorge Junior<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba<br>Made available in DSpace on 2018-08-24T16:42:54Z (GMT). No. of bitstreams: 1 SouzaLima_NathaliaCarolinede_M.pdf: 622004 bytes, checksum: 0c706eecc1567182559d2fa1ba1d3900 (MD5) Previous issue date: 2014<br>Resumo: Exposição a hormônios sexuais no início da vida pode influenciar a susceptibilidade às doenças relacionadas às diferenças de sexo. A proporção 2D:4D tem sido considerada um marcador putativo de exposição e sensibilidade pré-natal a hormônios sexuais

APA, Harvard, Vancouver, ISO, and other styles

10

Grundmark, Birgitta. "Prostate Cancer; Metabolic Risk Factors, Drug Utilisation, Adverse Drug Reactions." Doctoral thesis, Uppsala universitet, Institutionen för kirurgiska vetenskaper, 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-194297.

Full text

Abstract:

Increased possibilities during the last decades for early detection of prostate cancer have sparked research on preventable or treatable risk factors and on improvements in therapy. Treatments of the disease still entail significant side effects potentially affecting men during the rest of their lives. The studies of the present thesis concern different aspects of prostate cancer from etiological risk factors and factors influencing treatment to an improved methodology for the detection of treatment side effects. Papers I, II, both based in the population based cohort ULSAM (Uppsala Longitudin

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Cancer ratio"

1

Anscher, Mitchell S., and Kristoffer Valerie, eds. Strategies to Enhance the Therapeutic Ratio of Radiation as a Cancer Treatment. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-45594-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Bonavida, Benjamin, ed. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-474-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Benjamin, Bonavida, ed. Sensitization of cancer cells for chemo/immuno/radio-therapy. Humana Press, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

International Meeting on Progress in Radio-Oncology (6th 1998 Salzburg, Austria). Progress in radio-oncology VI: Proceedings of the 6th International Meeting on Progress in Radio-Oncology : ICRO/ ÖGRO 6 : Salzburg, Austria, May 13-17, 1998. Edited by Kogelnik H. Dieter and Sedlmayer Felix. Monduzzi Editore, International Proceedings Division, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

International Meeting on Progress in Radio-Oncology (5th 1995 Salzburg, Austria). Progress in radio-oncology V: Proceedings of the 5th International Meeting on Progress in Radio-Oncology, ICRO/ÖGRO 5, Salzburg (Austria), May 10-14, 1995. Edited by Kogelnik H. D. Monduzzi Editore, International Proceedings Division, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

International, Meeting on Progress in Radio-Oncology (7th 2002 Salzburg Austria). Progress in radio-oncology VII: Proceedings of the 7th International Meeting on Progress in Radio-Oncology, ICRO/ÖGRO 7 : Salzburg, Austria, May 15-19, 2002. Monduzzi Editore, International Proceedings Division, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Carlo, George Louis. Cell phones: Invisible hazards in the wireless age : an insider's alarming discoveries about cancer and genetic damage. Carroll & Graf Publishers, Inc., 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Abadie, Horacio. Charlemos de vos: Historias de vida en Abran Cancha. Planeta, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Strayed, Cheryl. Torch. Atlantic Books, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

C, Srivastava Suresh, and North Atlantic Treaty Organization. Scientific Affairs Division., eds. Radiolabeled monoclonal antibodies for imaging and therapy. Plenum Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Cancer ratio"

1

Keaton, Jeffrey R. "Poisson’s Ratio." In Selective Neck Dissection for Oral Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-12127-7_225-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Zhigalin, Aleksandr. "Velocity Ratio." In Selective Neck Dissection for Oral Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-12127-7_289-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Keaton, Jeffrey R. "California Bearing Ratio." In Selective Neck Dissection for Oral Cancer. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-12127-7_39-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Coderre, J. A., G. M. Morris, P. L. Micca, et al. "The Therapeutic Ratio in BNCT." In Cancer Neutron Capture Therapy. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4757-9567-7_107.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Stieve, Friedrich-Ernst. "A Topical View of the Benefit-Risk Ratio in Mammography." In Early Breast Cancer. Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70192-4_14.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rajan, Jay, Keth Pride, and Peggy Y. Kim. "Benefit to Burden Ratio in Treating Cancer Pain." In Pain. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99124-5_209.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Marcus, Pamela M. "Closing Thoughts." In Assessment of Cancer Screening. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-94577-0_10.

Full text

Abstract:

AbstractMost researchers believe that earlier detection due to cancer screening has led to some reduction in cancer mortality, though there is widespread disagreement as to the degree of its impact. There is general agreement, however, that cancer screening programs impact health care spending and availability of resources yet benefit only a few of those who are screened. There is less agreement regarding what constitutes benefit and harm, and even less regarding the acceptable ratio of harm to benefit. The predominant feeling among individuals in the general public is that cancer screening is

APA, Harvard, Vancouver, ISO, and other styles

8

Chung, Su I., DeeDee K. Smart, Eun Joo Chung, and Deborah E. Citrin. "Radioprotection as a Method to Enhance the Therapeutic Ratio of Radiotherapy." In Cancer Drug Discovery and Development. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40854-5_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Carruthers, Ross, and Anthony J. Chalmers. "Improving the Therapeutic Ratio of Radiotherapy by Targeting the DNA Damage Response." In Cancer Drug Discovery and Development. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40854-5_1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kamano, Toshiki, Kei Nakamura, Youshi Mikami, Noburu Sakakibara, Motonari Kano, and Masaru Matsumoto. "Significance of Fecal Bile Acid Ratio in Colorectal Cancer Patients." In Recent Advances in Management of Digestive Cancers. Springer Japan, 1993. http://dx.doi.org/10.1007/978-4-431-68252-3_134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cancer ratio"

1

Khan, Aamir A., Genevieve D. Vigil, Yide Zhang, and Scott S. Howard. "Theoretical Analysis of the Signal-to-Noise Ratio of Two-Photon Oxygen Imaging Probes." In Cancer Imaging and Therapy. OSA, 2016. http://dx.doi.org/10.1364/cancer.2016.jw3a.48.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Singh, Nisha, Deepshikha Rajput, and Shuchi Agrawal. "EP305/#401 Neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic markers in ovarian cancer." In IGCS 2023 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/ijgc-2023-igcs.368.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Huszno, J., Z. Kołosza, J. Mrochem Kwarciak, T. Rutkowski, and K. Składowski. "Abstract P2-08-49: The role of neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR) andmonocyte – lymphocyte ratio (MLR) in prognosis of breast cancer patients." In Abstracts: 2018 San Antonio Breast Cancer Symposium; December 4-8, 2018; San Antonio, Texas. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-p2-08-49.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Orlandini, Leonardo Fleury, Franklin Fernandes Pimentel, Jurandyr Moreira de Andrade, Francisco José Cândido dos Reis, Leticia De Mattos Arruda, and Daniel Guimarães Tiezzi. "HIGH NEUTROPHIL-TO-LYMPHOCYTE RATIO IS PROGNOSTIC FACTOR IN EARLY-STAGE BREAST CANCER PATIENTS." In Abstracts from the Brazilian Breast Cancer Symposium - BBCS 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s2038.

Full text

Abstract:

Objectives: We aimed to explore the association of a readily available biomarker of systemic inflammation, the neutrophil-to-lymphocyte ratio (NLR), with breast cancer survival. Methodology: We undertook a single-centered retrospective study of patients with stages I–III breast cancer from 1999 to 2013. Clinicopathological data were collected before receiving any type of treatment. Survival analysis was performed using Cox regression models and Kaplan–Meier curves. Results: The cutoff value for NLR was set at 4.0 (NLRhigh ≥ 4 and NLRlow < 4). Of 1,700 patients included in this study, 121 (7

APA, Harvard, Vancouver, ISO, and other styles

5

Zribi, Aref, Amnah Faisal Ahmed, Hasan Khalid Alsayegh, and Ikram A. Burney. "EV174/#209 Prognostic value of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in high-grade endometrial cancer." In IGCS 2024 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-igcs.293.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Das, B. B., R. R. Alfano, J. Cleary, R. Prudente, and E. Celmer. "UV-fluorescence spectroscopy distinguishes breast cancer from benign tumors." In OSA Annual Meeting. Optica Publishing Group, 1990. http://dx.doi.org/10.1364/oam.1990.tuoo7.

Full text

Abstract:

Breast cancer has one of the highest incidence and mortality rates in the U.S. X-ray mammography is one of the most common tools to diagnose breast cancer. Because of the effects of ionizing radiation and difficulty in differentiating benign from malignant tumors, there is a need for new methods. Fluorescence spectroscopy is a possible modality. We tested over 40 samples of cancerous and noncancerous breast tissues by means of UV-fluorescence spectroscopy. Each sample was excited in the UV, and the ratio of fluorescence intensities at different emission wavelengths were calculated. The ratio o

APA, Harvard, Vancouver, ISO, and other styles

7

Buttros, Daniel, Caroline Nakano Vitorino, Heloisa Maria de Luca Vespoli, Rafaela Caroline de Souza, and Eliana Aguiar Petri Nahás. "Negative impact of adjuvant endocrine therapy on sexual function in breast cancer survivors." In Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1037.

Full text

Abstract:

Objective: The objectives of this study were to evaluate the sexual function of postmenopausal breast cancer survivors compared with women without breast cancer and assess the impact of adjuvant breast cancer treatment on sexual function. Methodology: A cross-sectional study was conducted on 178 breast cancer survivors, stages I–III, age 45–70 years, amenorrhea for ³12 months, and sexually active, compared with 178 women with the same inclusion criteria, but without breast cancer. The groups were paired by age and menopause time, ratio 1:1. Sexual function was assessed using the Female Sexual

APA, Harvard, Vancouver, ISO, and other styles

8

Scelo, Ghislaine, Estelle Chanudet-van den Brink, Peng Li, Chanida Vinayanuwattikun, and David C. Muller. "Abstract 5213: Remarkably stable sex-ratio in sporadic kidney cancer incidence." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-5213.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mansouri, Houyem, Ines Zemni, Sabrine Boukhris, Houda Henchiri, Racha Ben Romdhan, and Leila Achouri. "399 Prognostic significance of lymph node ratio in early breast cancer." In ESGO 2024 Congress Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-esgo.844.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hayashi, Tomomi, Junichiro Watanabe, and Shyogo Nakamoto. "Abstract P1-10-25: The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab." In Abstracts: 2019 San Antonio Breast Cancer Symposium; December 10-14, 2019; San Antonio, Texas. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.sabcs19-p1-10-25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cancer ratio"

1

Zhang, Dan, Jingting Liu, Mengxia zheng, Chunyan Meng, and Jianhua Liao. Prognostic and Clinicopathological significance of CD155 Expression in Cancer Patients: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.9.0087.

Full text

Abstract:

Review question / Objective: The present study aimed to comprehensively explore the relationship between CD155 expression and clinical characteristics and prognosis of cancer patients. The study was based on comprehensive search of relevant literature. In particular, the study attempted to define the role of CD155 in various cancer types. Eligibility criteria: The pre-established inclusion criteria were as follows: (1) all subjects were cancer patients who received standard treatment; (2) The expression of CD155 in the cancer patients was well-examined, and all patients were assigned into two

APA, Harvard, Vancouver, ISO, and other styles

2

Kahwati, Leila, Matthew Avenarius, Leslie Brouwer, et al. Blood-Based Tests for Multiple Cancer Screening: A Systematic Review. AHRQ, 2025. https://doi.org/10.23970/ahrqepcsrmultiple.

Full text

Abstract:

Objectives. Screening for multiple cancers in a single blood test is potentially transformative. The objective of this review was to assess the benefits, harms, and accuracy of screening with blood-based multicancer screening tests (MCST) in asymptomatic adults. Data sources. Medline, Cochrane Library, trial registries, relevant government and commercial websites through December 2024; surveillance was conducted through March 31, 2025. Study Selection. Eligible designs included controlled studies for benefit outcomes (e.g., cancer mortality, cancer detection, quality of life), controlled and u

APA, Harvard, Vancouver, ISO, and other styles

3

Gupta, Arti, and Pankaj Kumar Gupta. HISTOPATHOLOGICAL DISTRIBUTION OF MALIGNANT CASES IN A TERTIARY CARE CENTRE. World Wide Journals, 2023. http://dx.doi.org/10.36106/ijar/1007787.

Full text

Abstract:

Introduction- Malignancy/cancer is a dreadful condition affecting not only physical but also mental wellbeing of a person. Surgeries associated with its treatment are also leads to morbidity. So apart from treatment we need to nd out the factors which are precipitating for any cancer.I tried to study the distribution of malignant cases received in histopathology lab of a tertiary care centre in two and a half month period with respect to its frequency, site,age gender and important histological types. In this study, we Resultshave seen 118 cases of malignancy in histopathology section in 2 an

APA, Harvard, Vancouver, ISO, and other styles

4

Hudson, Alana. The Impact of the 6:3 Polyunsaturated Fatty Acid Ratio on Intermediate Markers of Breast Cancer. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada485713.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hudson, Alana. The Impact of the 6:3 Polyunsaturated Fatty Acid Ratio on Intermediate Markers of Breast Cancer. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada471158.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Li, Binfeng, Fei Xiong, Shengzhong Yi, and Sheng Wang. Prognostic and Clinicopathologic Significance of Neutrophil-to-lymphocyte Ratio in Esophageal Cancer: An Update Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Su, Yanguang, Juanli Chen, Lingjun Du, and Xudong Liu. Prognostic and clinicopathological value of fibrinogen-to-albumin ratio (FAR) in colorectal cancer: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2025.3.0034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Zhang, Dongyuan, Zhengze Wang, Jingwen Li, Chengliang Ren, and Shen Tian. Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: An updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.9.0074.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Liu, Ye, Xiaodi Li, Xiaoli Gao, and Xiaoling Jin. Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in patients with esophageal cancer: A meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.6.0005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Yang, Fan, Zhaofeng Wang, and Minming Wang. Prognostic value of lymphocyte-to-monocyte ratio in patients with small cell lung cancer: a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2025. https://doi.org/10.37766/inplasy2025.7.0051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!